SGLT2 inhibitors are a new family of agents, which occlude the path of SGLT2 glucose reabsorption and cause glucosuria. Efficacy of SGLT2 inhibitors includes reduction of HbA1c, fasting and ...
Meaghan Senn is a writer from North Carolina with experience in B2B, technology and digital marketing topics. Throughout her career, Meaghan has worked with B2B, software and digital marketing ...
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors — a class of drugs used to treat type 2 diabetes — could also prevent dementia, according to a study published Wednesday in The BMJ.
Adding an SGLT2 inhibitor to standard care did not ... Sanofi, scPharmaceuticals, Structure Therapeutics, Vifor Pharma, ...
In fact, each gene in cellular DNA contains the code for a unique protein structure. Not only are these proteins assembled with different amino acid sequences, but they also are held together by ...
New findings add to the pile of research on the possible neuroprotective effects of drugs like dapagliflozin, empagliflozin, and dulaglutide for patients with type 2 diabetes. New research ...
New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...
Minimum investments vary for each fund, the structure of private equity funds historically follows a framework that includes classes of fund partners, management fees, investment horizons ...
The researchers found that during a median follow-up of 4.4 years, the primary outcome event of presumed clinical onset of dementia occurred in 69 and 43 participants in the SGLT2 and dulaglutide ...
The structure, which dates back to the sixth century B.C., was discovered three years ago during excavations of a site in the ancient city of Buto, now Tell Al-Faraeen, within Egypt's Kafr El ...
Renal glucose reabsorption involves two transporter families: the SGLTs secondary active Na + /D-glucose co-transporters located at the brush border of tubular cells (SGLT2 and SGLT1) and the ...